pentetic acid has been researched along with Cancer of Pancreas in 108 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Excerpt | Relevance | Reference |
---|---|---|
"Recently, we have shown that the expression of receptors for vasoactive intestinal peptide (VIP) on intestinal adenocarcinomas can be used for in vivo targeting of primary or metastatic tumor sites using 123I-labeled VIP." | 5.08 | Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy. ( Angelberger, P; Becherer, A; Kletter, K; Kornek, G; Kurtaran, A; Leimer, M; Li, S; Raderer, M; Scheithauer, W; Virgolini, I; Weinlaender, G, 1996) |
"The increased expression of the neurotensin (NT) receptor NTS1 by different cancer cells, such as pancreatic adenocarcinoma and ductal breast cancer cells, as compared to normal epithelium, offers the opportunity to target these tumors with radiolabeled neurotensin analogues for diagnostic or therapeutic purposes." | 3.75 | Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors. ( Abdelhak, J; Alshoukr, F; Barbet, J; Burg, S; Gruaz-Guyon, A; Maes, V; Pelaprat, D; Raguin, O; Rosant, C; Sarda, L; Tourwé, D, 2009) |
"Small benign insulinomas are hard to localise, leading to difficulties in planning of surgical interventions." | 2.78 | Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study. ( Béhé, M; Brändle, M; Caplin, ME; Christ, E; Clerici, T; Ederer, S; Ell, PJ; Fischli, S; Forrer, F; Gloor, B; Nicolas, G; Perren, A; Reubi, JC; Seufert, J; Stettler, C; Wild, D, 2013) |
"In patients with midgut carcinoids, (all scintigraphy positive), false Rin situ recordings were found in 4/29 macroscopically identified tumours." | 2.68 | Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide. ( Ahlman, H; Fjalling, M; Forssell-Aronsson, E; Nilsson, O; Tisell, LE; Wangberg, B, 1996) |
"They can be subdivided into the carcinoid tumors of the gastrointestinal submucosa and the islet cell endocrine tumors of the pancreas." | 2.40 | Recent advances in diagnosis and therapy of neuroendocrine tumors of the gastrointestinal tract. ( Bukowski, RM; Pelley, RJ, 1997) |
"A 51-year-old woman was found to have a recurrence 23 months after laparoscopic distal pancreatectomy, splenectomy and wedge resection of a liver metastasis for a non-functional neuroendocirne neoplasm of the pancreas." | 1.35 | Intraoperative hand held gamma probe detection of a recurrent nonfunctional neuroendocrine tumor. ( Fitzgerald, TL; Van Haren, RM, 2008) |
"Ferritin is overexpressed in pancreatic cancer and could thus be used as a target for the delivery of radioactivity at the tumour sites." | 1.34 | In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer. ( Decaudin, D; Ellison, D; Finucane, C; Kadouche, J; Mather, SJ; Sabbah, EN, 2007) |
"CFPAC-1, PANC-1 and CAPAN-1 pancreatic cancer cell clusters and pancreatic tumor xenografts show high expression of the MUC-1 target antigen." | 1.33 | In vivo and in vitro inhibition of pancreatic cancer growth by targeted alpha therapy using 213Bi-CHX.A"-C595. ( Allen, BJ; Brechbiel, M; Li, Y; Morgenstern, A; Perkins, AC; Qu, CF; Rizvi, SM; Smith, R; Songl, YJ, 2005) |
"Insulinomas are rare endocrine tumors that are mostly sporadic, benign, and small." | 1.33 | Intraoperative gamma probe detection of lymph node recurrence of insulinoma. ( Busquets, J; Grande, L; Miralles, EM; Miret, M; Munné, A; Ortega, M; Pelaez, N; Puig, J, 2005) |
"Malignant carcinoid tumors express high numbers of somatostatin receptors." | 1.32 | GOT1 xenografted to nude mice: a unique model for in vivo studies on SSTR-mediated radiation therapy of carcinoid tumors. ( Ahlman, H; Bernhardt, P; Forssell-Aronsson, E; Johanson, V; Kölby, L; Nilsson, O, 2004) |
"Insulinoma is a rare endocrine tumour in the elderly." | 1.31 | Intraoperative gamma probe detection of insulinoma in an elderly patient with pancreatic cystic lesions. ( Donckier, JE; Ernst, YJ; Michel, L; Roelants, V; Rosière, A; Vander Borght, T, 2002) |
"In this report, imaging of a glucagonoma with In-111 DTPA-D-PHE1 octreotide scintigraphy is described in a 51-year-old woman examined for a large palpable abdominal mass." | 1.31 | Current imaging and possible therapeutic management of glucagonoma tumors: a case report. ( Bornemann, M; Coel, MN; Johnson, DS, 2000) |
"Patient 1 had a metastatic follicular thyroid carcinoma, patient 2 a metastatic medullary thyroid carcinoma, patient 3 tuberculosis and patient 4 an insulinoma." | 1.30 | Somatostatin receptor scintigraphy using [111In-DTPA0]RC-160 in humans: a comparison with [111In-DTPA0]octreotide. ( Breeman, WA; Krenning, EP; Kwekkeboom, DJ; van Hagen, PM; Visser, TJ, 1998) |
"The results of SRS and octreotide treatment in three somatostatinoma patients were examined." | 1.30 | Use of the somatostatin analogue octreotide to localise and manage somatostatin-producing tumours. ( Angeletti, S; Annibale, B; Basso, N; Bordi, C; Corleto, VD; Delle Fave, G; Marignani, M; Moretti, A; Schillaci, O; Scopinaro, F; Silecchia, G, 1998) |
"For midgut carcinoids, the tumor-to-blood ratio was 51:220, for medullary thyroid carcinoma 4:39, and for two endocrine pancreatic tumors 6 and 1500." | 1.29 | Indium-111 activity concentration in tissue samples after intravenous injection of indium-111-DTPA-D-Phe-1-octreotide. ( Ahlman, H; Fjälling, M; Forssell-Aronsson, E; Nilsson, O; Tisell, LE; Wängberg, B, 1995) |
"Ten patients with 11 islet cell tumors underwent dynamic contrast material-enhanced computed tomography (CT) and magnetic resonance (MR) imaging within a 1-month period." | 1.29 | Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression. ( Cumming, MJ; Greenberg, HM; Kroeker, MA; Magro, CM; Semelka, RC; Shoenut, JP; Yaffe, CS, 1993) |
"Even 24 h post injection, the islet cell tumor was still detectable." | 1.29 | OctreoScan 111 for imaging of a somatostatin receptor-positive islet cell tumor in rat. ( Albert, R; Bruns, C; Marbach, P; Pless, J; Stolz, B, 1993) |
"The contrast-to-noise ratio between the pancreatic cancer and the surrounding pancreatic parenchyma was significantly higher with the dynamic 3DFT-FLASH image than with the conventional SE images (p<0." | 1.29 | 3DFT-flash MR imaging of pancreatic cancer with gadopentetate dimeglumine. ( Hori, S; Miyata, M; Monden, M; Murakami, T; Nakamura, H; Osuga, K; Tomoda, K; Tsuda, K; Wakasa, K, 1996) |
"In patients with carcinoids, a combination of somatostatin receptor scintigraphy, chest radiograph and ultrasound of the upper abdomen had a high sensitivity for tumor localization, and detected lesions in patients in whom no tumor was found with conventional imaging, justifying the greater cost." | 1.29 | Cost-effectiveness analysis of somatostatin receptor scintigraphy. ( Habbema, JD; Krenning, EP; Kwekkeboom, DJ; Lamberts, SW, 1996) |
"In midgut carcinoid (MC) patients (all scintigraphy positive), 4/29 macroscopically identified tumours gave false R(in situ)." | 1.29 | Radioisotope-guided surgery in patients with neuroendocrine tumours. ( Ahlman, H, 1996) |
"MRI of surgical specimens revealed that pancreatic cancer and caudal pancreatitis showed similar intensities when compared with the normal pancreas." | 1.28 | [Studies on magnetic resonance imaging of pancreatic cancer]. ( Hirose, Y, 1991) |
"Gadolinium (Gd)-DTPA was evaluated as a contrast agent for magnetic resonance (MR) imaging of the pancreas at 1." | 1.28 | Magnetic resonance imaging of the pancreas with gadolinium-DTPA. ( Bernardino, ME; Chezmar, JL; Nelson, RC; Small, WC, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (3.70) | 18.7374 |
1990's | 63 (58.33) | 18.2507 |
2000's | 27 (25.00) | 29.6817 |
2010's | 13 (12.04) | 24.3611 |
2020's | 1 (0.93) | 2.80 |
Authors | Studies |
---|---|
Smeets, EMM | 1 |
Dorst, DN | 1 |
Franssen, GM | 1 |
van Essen, MS | 1 |
Frielink, C | 1 |
Stommel, MWJ | 1 |
Trajkovic-Arsic, M | 1 |
Cheung, PF | 1 |
Siveke, JT | 1 |
Wilson, I | 1 |
Mascioni, A | 1 |
Aarntzen, EHJG | 1 |
van Lith, SAM | 1 |
Hasegawa, S | 1 |
Kobayashi, N | 1 |
Tokuhisa, M | 1 |
Goto, A | 1 |
Takano, S | 1 |
Takada, Y | 1 |
Kaneta, T | 1 |
Mori, R | 1 |
Matsuyama, R | 1 |
Endo, I | 1 |
Yamanaka, S | 1 |
Nakajima, A | 1 |
Inoue, T | 1 |
Ichikawa, Y | 1 |
Cuccurullo, V | 1 |
Di Stasio, GD | 1 |
Mansi, L | 1 |
Bol, K | 1 |
Haeck, JC | 1 |
Groen, HC | 1 |
Niessen, WJ | 1 |
Bernsen, MR | 1 |
de Jong, M | 13 |
Veenland, JF | 1 |
Grossman, A | 1 |
Christ, E | 1 |
Wild, D | 2 |
Ederer, S | 1 |
Béhé, M | 3 |
Nicolas, G | 1 |
Caplin, ME | 1 |
Brändle, M | 1 |
Clerici, T | 1 |
Fischli, S | 1 |
Stettler, C | 1 |
Ell, PJ | 1 |
Seufert, J | 1 |
Gloor, B | 1 |
Perren, A | 1 |
Reubi, JC | 7 |
Forrer, F | 1 |
Pool, SE | 1 |
Kam, BL | 1 |
Koning, GA | 1 |
Konijnenberg, M | 1 |
Ten Hagen, TL | 1 |
Breeman, WA | 11 |
Krenning, EP | 17 |
van Eijck, CH | 3 |
Deppen, SA | 1 |
Blume, J | 1 |
Bobbey, AJ | 1 |
Shah, C | 1 |
Graham, MM | 1 |
Lee, P | 1 |
Delbeke, D | 1 |
Walker, RC | 1 |
Brabander, T | 1 |
Teunissen, J | 1 |
Kwekkeboom, D | 1 |
Good, S | 1 |
Walter, MA | 2 |
Waser, B | 2 |
Wang, X | 1 |
Müller-Brand, J | 1 |
Béhé, MP | 1 |
Maecke, HR | 2 |
Van Haren, RM | 1 |
Fitzgerald, TL | 1 |
Alshoukr, F | 1 |
Rosant, C | 1 |
Maes, V | 1 |
Abdelhak, J | 1 |
Raguin, O | 1 |
Burg, S | 1 |
Sarda, L | 1 |
Barbet, J | 1 |
Tourwé, D | 1 |
Pelaprat, D | 1 |
Gruaz-Guyon, A | 1 |
Vervoort, L | 1 |
Burvenich, I | 1 |
Staelens, S | 1 |
Dumolyn, C | 1 |
Waegemans, E | 1 |
Van Steenkiste, M | 1 |
Baird, SK | 1 |
Scott, AM | 1 |
De Vos, F | 1 |
Helbok, A | 1 |
Rangger, C | 1 |
von Guggenberg, E | 1 |
Saba-Lepek, M | 1 |
Radolf, T | 1 |
Thurner, G | 1 |
Andreae, F | 1 |
Prassl, R | 1 |
Decristoforo, C | 1 |
Ferone, D | 1 |
Pivonello, R | 1 |
Kwekkeboom, DJ | 12 |
Gatto, F | 1 |
Ameri, P | 1 |
Colao, A | 1 |
de Krijger, RR | 1 |
Minuto, F | 1 |
Lamberts, SW | 8 |
van Hagen, PM | 2 |
Hofland, LJ | 4 |
Schreiter, NF | 1 |
Brenner, W | 1 |
Nogami, M | 1 |
Buchert, R | 1 |
Huppertz, A | 1 |
Pape, UF | 1 |
Prasad, V | 1 |
Hamm, B | 2 |
Maurer, MH | 1 |
Ruf, J | 1 |
Rosière, A | 1 |
Ernst, YJ | 1 |
Roelants, V | 1 |
Vander Borght, T | 1 |
Michel, L | 1 |
Donckier, JE | 1 |
Capello, A | 2 |
Bernard, BF | 4 |
de Visser, M | 1 |
Janssen, PJ | 1 |
Srinivasan, A | 2 |
Erion, JL | 1 |
Schmidt, MA | 1 |
Wang, M | 1 |
Caruano, AL | 1 |
Lewis, MR | 1 |
Meyer, LA | 1 |
VanderWaal, RP | 1 |
Anderson, CJ | 4 |
Nilsson, O | 3 |
Kölby, L | 1 |
Bernhardt, P | 1 |
Forssell-Aronsson, E | 3 |
Johanson, V | 1 |
Ahlman, H | 4 |
Dimitroulopoulos, D | 1 |
Xynopoulos, D | 1 |
Tsamakidis, K | 1 |
Paraskevas, E | 1 |
Zisimopoulos, A | 1 |
Andriotis, E | 1 |
Fotopoulou, E | 1 |
Kontis, M | 1 |
Paraskevas, I | 1 |
Mueller-Brand, J | 1 |
Paganelli, G | 1 |
Anthony, LB | 1 |
Pauwels, S | 4 |
Kvols, LK | 2 |
O'dorisio, TM | 1 |
Valkema, R | 4 |
Bodei, L | 1 |
Chinol, M | 1 |
Krenning, E | 2 |
Bernard, B | 1 |
Breeman, W | 1 |
Qu, CF | 1 |
Songl, YJ | 1 |
Rizvi, SM | 1 |
Li, Y | 1 |
Smith, R | 1 |
Perkins, AC | 1 |
Morgenstern, A | 1 |
Brechbiel, M | 1 |
Allen, BJ | 1 |
Pelaez, N | 1 |
Busquets, J | 1 |
Ortega, M | 1 |
Miralles, EM | 1 |
Puig, J | 1 |
Miret, M | 1 |
Munné, A | 1 |
Grande, L | 1 |
Storch, D | 2 |
Chen, J | 1 |
Powell, P | 1 |
Mikolajczak, R | 1 |
Mäcke, HR | 4 |
Teunissen, JJ | 1 |
Esser, JP | 1 |
Valero, M | 1 |
Boán, JF | 1 |
Rodriguez-Spiteri, N | 1 |
Torre, W | 1 |
Richter, JA | 1 |
Lin, YC | 1 |
Hung, GU | 1 |
Luo, TY | 1 |
Chen, CH | 1 |
Hsia, CC | 1 |
Hen, SL | 1 |
Ho, YJ | 1 |
Lin, WY | 1 |
Hanaoka, H | 1 |
Mukai, T | 1 |
Tamamura, H | 1 |
Mori, T | 1 |
Ishino, S | 1 |
Ogawa, K | 1 |
Iida, Y | 1 |
Doi, R | 1 |
Fujii, N | 1 |
Saji, H | 1 |
Sabbah, EN | 1 |
Kadouche, J | 1 |
Ellison, D | 1 |
Finucane, C | 1 |
Decaudin, D | 1 |
Mather, SJ | 1 |
Wicki, A | 1 |
Seemayer, C | 1 |
Gotthardt, M | 1 |
Kneifel, S | 1 |
Mihatsch, MJ | 1 |
Christofori, G | 1 |
Carr, DH | 1 |
Rolleman, EJ | 1 |
Visser, TJ | 7 |
Setyono-Han, B | 3 |
Bakker, WH | 7 |
van der Pluijm, ME | 2 |
Oei, HY | 3 |
de Jong, RJ | 2 |
Dop, FJ | 2 |
de Herder, WW | 2 |
Modlin, IM | 1 |
Cornelius, E | 1 |
Lawton, GP | 1 |
Eising, EG | 1 |
Farahati, J | 1 |
Bier, D | 1 |
Knust, EJ | 1 |
Reiners, C | 1 |
Brown, ED | 1 |
Semelka, RC | 4 |
Sittek, H | 1 |
Heuck, AF | 1 |
Fölsing, C | 1 |
Gieseke, J | 1 |
Reiser, M | 1 |
Fjälling, M | 2 |
Tisell, LE | 2 |
Wängberg, B | 2 |
Weinel, RJ | 1 |
Kisker, O | 1 |
Joseph, K | 2 |
Welcke, U | 1 |
Zaraca, F | 1 |
Rothmund, M | 1 |
de Kerviler, E | 1 |
Cadiot, G | 1 |
Lebtahi, R | 1 |
Faraggi, M | 1 |
Le Guludec, D | 1 |
Mignon, M | 1 |
van der Pluijm, M | 1 |
van Koetsveld, PM | 1 |
Krausz, Y | 2 |
Ish-Shalom, S | 1 |
Lapidot, M | 1 |
Glaser, B | 2 |
Gabata, T | 1 |
Matsui, O | 1 |
Kadoya, M | 1 |
Yoshikawa, J | 1 |
Miyayama, S | 1 |
Takashima, T | 1 |
Nagakawa, T | 1 |
Kayahara, M | 1 |
Nonomura, A | 1 |
Kooij, PP | 2 |
Postema, PT | 2 |
Reijs, AE | 1 |
Leners, N | 1 |
Fiasse, R | 1 |
Jamar, F | 2 |
Wiedenmann, B | 1 |
Bäder, HM | 1 |
Scherubl, H | 1 |
Fett, U | 1 |
Zimmer, T | 1 |
Koppenhagen, K | 1 |
Riecken, EO | 1 |
Hagspiel, KD | 1 |
Neidl, KF | 1 |
Hauser, M | 1 |
Duewell, S | 1 |
Marincek, B | 1 |
Shibley, N | 1 |
De Jong, RB | 1 |
Yaffe, S | 1 |
Adrian, HJ | 1 |
Dörr, U | 1 |
Bach, D | 1 |
Bihl, H | 1 |
Stapp, J | 1 |
Reinecke, J | 1 |
Skamel, HJ | 1 |
Höffken, H | 1 |
Neuhaus, C | 1 |
Lenze, H | 1 |
Trautmann, ME | 1 |
Arnold, R | 1 |
Cumming, MJ | 1 |
Shoenut, JP | 2 |
Magro, CM | 1 |
Yaffe, CS | 2 |
Kroeker, MA | 2 |
Greenberg, HM | 1 |
Arnberg, H | 1 |
Westlin, JE | 1 |
Husin, S | 1 |
Nilsson, S | 1 |
Bruns, C | 2 |
Stolz, B | 2 |
Albert, R | 2 |
Marbach, P | 1 |
Pless, J | 1 |
Chayvialle, JA | 1 |
Ward, J | 1 |
Martinéz, D | 1 |
Chalmers, AG | 1 |
Ridgway, J | 1 |
Robinson, PJ | 1 |
Smith, MA | 1 |
Pajeau, TS | 1 |
Edwards, WB | 1 |
Sherman, EL | 1 |
Rogers, BE | 1 |
Welch, MJ | 1 |
VanHagen, MP | 1 |
Visser-Wisselaar, HA | 2 |
Koper, JW | 1 |
Hazenberg, MP | 1 |
Yamamoto, K | 1 |
Ishii, Y | 1 |
Furudate, M | 1 |
Ito, K | 1 |
Tsukamoto, E | 1 |
Kanamaru, R | 1 |
Endo, K | 1 |
Hirano, T | 1 |
Tanaka, K | 1 |
Ogino, Y | 1 |
Murakami, T | 1 |
Tsuda, K | 1 |
Nakamura, H | 1 |
Osuga, K | 1 |
Tomoda, K | 1 |
Hori, S | 1 |
Miyata, M | 1 |
Monden, M | 1 |
Wakasa, K | 1 |
Kettritz, U | 1 |
Habbema, JD | 1 |
Cardone, G | 1 |
Di Girolamo, M | 1 |
Messina, A | 1 |
Chichiarelli, A | 1 |
Corsetti, A | 1 |
Di Cesare, E | 1 |
Lupattelli, L | 1 |
Passariello, R | 1 |
Pearson, DA | 1 |
Lister-James, J | 1 |
McBride, WJ | 1 |
Wilson, DM | 1 |
Martel, LJ | 1 |
Civitello, ER | 1 |
Taylor, JE | 1 |
Moyer, BR | 1 |
Dean, RT | 1 |
Tani, A | 1 |
Nakabeppu, Y | 1 |
Tsuchimochi, S | 1 |
Nakajo, M | 1 |
Yoshinaga, T | 1 |
Kiku, T | 1 |
Silberstein, EB | 1 |
Saeks, E | 1 |
Lentschig, MG | 1 |
Reimer, P | 1 |
Rummeny, E | 1 |
Grenzheuser, C | 1 |
Daldrup, HE | 1 |
Berns, T | 1 |
Dinse, P | 1 |
Sulkowski, U | 1 |
Peters, PE | 1 |
Raderer, M | 1 |
Becherer, A | 1 |
Kurtaran, A | 1 |
Angelberger, P | 1 |
Li, S | 1 |
Leimer, M | 1 |
Weinlaender, G | 1 |
Kornek, G | 1 |
Kletter, K | 1 |
Scheithauer, W | 1 |
Virgolini, I | 1 |
Sironi, S | 1 |
De Cobelli, F | 1 |
Zerbi, A | 1 |
Angeli, E | 1 |
Balzano, G | 1 |
Taccagni, G | 1 |
Di Carlo, V | 1 |
Del Maschio, A | 1 |
Termanini, B | 1 |
Gibril, F | 1 |
Doppman, JL | 1 |
Reynolds, JC | 1 |
Stewart, CA | 1 |
Sutliff, VE | 1 |
Venzon, DJ | 1 |
Jensen, RT | 1 |
Duncan, JR | 1 |
Stephenson, MT | 1 |
Wu, HP | 1 |
Pelley, RJ | 1 |
Bukowski, RM | 1 |
Engelhard, K | 1 |
Hollenbach, HP | 1 |
Schillaci, O | 3 |
Annibale, B | 3 |
Scopinaro, F | 3 |
delle Fave, G | 3 |
Colella, AC | 1 |
Robben, JH | 1 |
Rutteman, GR | 1 |
van Rijk, PP | 1 |
van Dongen, AJ | 1 |
Voorhout, G | 1 |
van den Ingh, TS | 1 |
Adams, S | 1 |
Baum, R | 1 |
Rink, T | 1 |
Schumm-Dräger, PM | 1 |
Usadel, KH | 1 |
Hör, G | 1 |
Chiti, A | 1 |
Spinelli, A | 1 |
Bombardieri, E | 1 |
Smith-Jones, PM | 1 |
Ruser, G | 1 |
Briner, U | 1 |
De Bruin, E | 1 |
Van Gameren, A | 1 |
Shi, W | 1 |
Johnston, CF | 1 |
Buchanan, KD | 1 |
Ferguson, WR | 1 |
Laird, JD | 1 |
Crothers, JG | 1 |
McIlrath, EM | 1 |
Angeletti, S | 1 |
Corleto, VD | 2 |
Marignani, M | 1 |
Moretti, A | 1 |
Silecchia, G | 1 |
Basso, N | 1 |
Bordi, C | 1 |
Slooter, GD | 1 |
Marquet, RL | 1 |
Hishinuma, S | 1 |
Ogata, Y | 1 |
Matsui, J | 1 |
Ozawa, I | 1 |
Johnson, DS | 1 |
Coel, MN | 1 |
Bornemann, M | 1 |
Banzo, J | 1 |
Abós, MD | 1 |
Prats, E | 1 |
García, F | 1 |
Razola, P | 1 |
Dehdashti, F | 1 |
Cutler, PD | 1 |
Schwarz, SW | 1 |
Laforest, R | 1 |
Bass, LA | 1 |
Lewis, JS | 1 |
McCarthy, DW | 1 |
Ichijo, T | 1 |
Ishikawa, M | 1 |
Shimojo, M | 1 |
Tsubuku, M | 1 |
Tsuboi, K | 1 |
Miyachi, Y | 1 |
Smith, C | 1 |
Hirose, Y | 1 |
Neumann, K | 1 |
Kaminsky, S | 1 |
Gogoll, M | 1 |
Clauss, W | 1 |
Langer, M | 1 |
Felix, R | 1 |
Kroeker, R | 1 |
Micflikier, AB | 1 |
Chezmar, JL | 1 |
Nelson, RC | 1 |
Small, WC | 1 |
Bernardino, ME | 1 |
Bosslet, K | 2 |
Steinstraesser, A | 2 |
Hermentin, P | 1 |
Kuhlmann, L | 2 |
Bruynck, A | 1 |
Magerstaedt, M | 1 |
Seemann, G | 1 |
Schwarz, A | 2 |
Sedlacek, HH | 1 |
Mehta, MP | 1 |
Kubsad, SS | 1 |
Fowler, JF | 1 |
Verma, AK | 1 |
Hsieh, JT | 1 |
Kinsella, TJ | 1 |
Langkowski, JH | 1 |
Seidel, L | 1 |
Schulz, G | 1 |
Al-Suhaili, AR | 1 |
Ericsson, S | 1 |
Bahar, RH | 1 |
Nawaz, MK | 1 |
Abdel-Dayem, HM | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
New Imaging Procedure for the Localisation of Insulinoma[NCT02127541] | 52 participants (Actual) | Interventional | 2014-01-06 | Completed | |||
Diagnostic Accuracy of 68Gallium Positron Emission Tomography/ Magnetic Resonance Imaging (68Ga PET/MRI), Endoscopic Ultrasound (EUS) and Computed Tomography in the Assessment of Lymph Node Metastases by Nonfunctioning Pancreatic Neuroendocrine Neoplasms[NCT03918759] | 100 participants (Actual) | Observational | 2018-11-01 | Completed | |||
Peptide Receptor Radionuclide Therapy (PRRT) in Tumors With High Expression of Somatostatin Receptors[NCT04790708] | 250 participants (Anticipated) | Interventional | 2018-07-02 | Recruiting | |||
Molecular and Whole-body MR Imaging in Lymphomas[NCT02389101] | 21 participants (Actual) | Interventional | 2014-10-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Uptake of 68Ga-DOTANOC in lymphoma expressed as SUVmax (NCT02389101)
Timeframe: Within 30 days prior to start of chemotherapy
Intervention | Standardized Uptake Value (Median) |
---|---|
Lymphoma | 3.1 |
16 reviews available for pentetic acid and Cancer of Pancreas
Article | Year |
---|---|
Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours.
Topics: Animals; Dihydroxyphenylalanine; Dimerization; Edetic Acid; Fluorodeoxyglucose F18; Glucagon-Like Pe | 2019 |
68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.
Topics: Humans; Intestinal Neoplasms; Lung Neoplasms; Neuroendocrine Tumors; Octreotide; Organometallic Comp | 2016 |
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
Topics: Animals; Clinical Trials as Topic; Drug Delivery Systems; Drug Evaluation, Preclinical; Gastrointest | 2005 |
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
Topics: Animals; Clinical Trials as Topic; Drug Delivery Systems; Drug Evaluation, Preclinical; Gastrointest | 2005 |
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
Topics: Animals; Clinical Trials as Topic; Drug Delivery Systems; Drug Evaluation, Preclinical; Gastrointest | 2005 |
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
Topics: Animals; Clinical Trials as Topic; Drug Delivery Systems; Drug Evaluation, Preclinical; Gastrointest | 2005 |
Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy.
Topics: Animals; Carcinoma, Neuroendocrine; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Luteti | 2005 |
Use of an isotopic somatostatin receptor probe to image gut endocrine tumors.
Topics: Adult; Aged; Carcinoid Tumor; Duodenal Neoplasms; Female; Gastrinoma; Humans; Indium Radioisotopes; | 1995 |
Magnetic resonance imaging of the spleen and pancreas.
Topics: Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pancr | 1995 |
[Somatostatin-receptor imaging in endocrine tumors].
Topics: Endocrine Gland Neoplasms; Humans; Multiple Endocrine Neoplasia; Octreotide; Pancreatic Neoplasms; P | 1994 |
Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results.
Topics: Europe; Humans; Indium Radioisotopes; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Pancre | 1994 |
The visualization of gastroenteropancreatic endocrine tumors.
Topics: Adenoma, Islet Cell; Carcinoid Tumor; Diagnostic Imaging; Gastrointestinal Neoplasms; Humans; Indium | 1993 |
Contrast-enhanced MR imaging of the pancreas.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Mangan | 1996 |
Recent advances in diagnosis and therapy of neuroendocrine tumors of the gastrointestinal tract.
Topics: Adenoma, Islet Cell; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols | 1997 |
[The scintigraphy of somatostatin receptors in gastroenteropancreatic neuroendocrine tumors].
Topics: Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Neuroendocrine Tumors; Octreotide; Pancrea | 1997 |
Somatostatin receptor imaging and therapy of pancreatic endocrine tumors.
Topics: Apudoma; Humans; Indium Radioisotopes; Octreotide; Pancreatic Neoplasms; Pentetic Acid; Receptors, S | 1999 |
Single photon emission computed tomography procedure improves accuracy of somatostatin receptor scintigraphy in gastro-entero pancreatic tumours.
Topics: Female; Gastrointestinal Neoplasms; Humans; Male; Neuroendocrine Tumors; Octreotide; Pancreatic Neop | 1999 |
[Scintigraphy of somatostatin receptors in the diagnosis and staging of neuroendocrine tumors of the digestive tract and pancreas].
Topics: Algorithms; Animals; Binding, Competitive; Biomarkers, Tumor; Clinical Trials, Phase I as Topic; Gas | 2000 |
Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.
Topics: Animals; Humans; Indium Radioisotopes; Liver Neoplasms; Neuroendocrine Tumors; Octreotide; Organomet | 2002 |
8 trials available for pentetic acid and Cancer of Pancreas
Article | Year |
---|---|
Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study.
Topics: Adult; Aged; Aged, 80 and over; Exenatide; Female; Glucagon-Like Peptide-1 Receptor; Humans; Indium | 2013 |
Scintigraphic detection of carcinoid tumors with a cost effectiveness analysis.
Topics: Adult; Aged; Carcinoid Tumor; Cost-Benefit Analysis; Female; Gastrointestinal Neoplasms; Humans; Ind | 2004 |
Use of an isotopic somatostatin receptor probe to image gut endocrine tumors.
Topics: Adult; Aged; Carcinoid Tumor; Duodenal Neoplasms; Female; Gastrinoma; Humans; Indium Radioisotopes; | 1995 |
[Phase 3 multicenter clinical study of 111In-DTPA-D-octreotide (MP-1727) in patients with gastrointestinal hormone producing tumors].
Topics: Adult; Aged; Carcinoid Tumor; Female; Gastrinoma; Glucagonoma; Humans; Indium Radioisotopes; Insulin | 1995 |
Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide.
Topics: Carcinoid Tumor; Female; Humans; Indium Radioisotopes; Intraoperative Care; Neuroendocrine Tumors; O | 1996 |
Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Female; Gastrointestinal Neoplasms; Humans; Indium Radioisot | 1996 |
Somatostatin receptor: scintigraphy and radionuclide therapy.
Topics: Humans; Indium Radioisotopes; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Pentetic Acid | 1996 |
Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gastrointestinal Agents; Humans; Image Processing, Comp | 1998 |
85 other studies available for pentetic acid and Cancer of Pancreas
Article | Year |
---|---|
Fibroblast Activation Protein-Targeting Minibody-IRDye700DX for Ablation of the Cancer-Associated Fibroblast with Photodynamic Therapy.
Topics: Animals; Cancer-Associated Fibroblasts; Fibroblasts; Membrane Proteins; Mice; Pancreatic Neoplasms; | 2023 |
Clinical Usefulness of Somatostatin Receptor Scintigraphy in Japanese Patients with Gastroenteropancreatic Neuroendocrine Tumors.
Topics: Adult; Aged; Female; Humans; Immunohistochemistry; Intestinal Neoplasms; Japan; Liver; Male; Middle | 2017 |
Can DCE-MRI explain the heterogeneity in radiopeptide uptake imaged by SPECT in a pancreatic neuroendocrine tumor model?
Topics: Animals; Contrast Media; Indium Radioisotopes; Magnetic Resonance Imaging; Male; Neuroendocrine Tumo | 2013 |
The nuclear option for insulinomas.
Topics: Exenatide; Female; Humans; Indium Radioisotopes; Insulinoma; Male; Pancreatic Neoplasms; Pentetic Ac | 2013 |
[(111)In-DTPA]octreotide tumor uptake in GEPNET liver metastases after intra-arterial administration: an overview of preclinical and clinical observations and implications for tumor radiation dose after peptide radionuclide therapy.
Topics: Adult; Animals; Disease Models, Animal; Female; Humans; Indium Radioisotopes; Infusions, Intra-Arter | 2014 |
Physiological Uptake in the Pancreatic Head on Somatostatin Receptor Scintigraphy Using [111In-DTPA]Octreotide: Incidence and Mechanism.
Topics: Humans; Neuroendocrine Tumors; Octreotide; Pancreas; Pancreatic Neoplasms; Pentetic Acid; Protein Bi | 2017 |
Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours.
Topics: Animals; Cell Line, Tumor; Chelating Agents; Drug Delivery Systems; Gastrins; Macrocyclic Compounds; | 2008 |
Intraoperative hand held gamma probe detection of a recurrent nonfunctional neuroendocrine tumor.
Topics: Carcinoma, Neuroendocrine; Female; Gamma Rays; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle | 2008 |
Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Indium Radioisotopes; L | 2009 |
Preclinical evaluation of monoclonal antibody 14C5 for targeting pancreatic cancer.
Topics: Animals; Antibodies, Monoclonal; Drug Evaluation, Preclinical; Female; Humans; Iodine Radioisotopes; | 2010 |
Targeting properties of peptide-modified radiolabeled liposomal nanoparticles.
Topics: Animals; Cell Line, Tumor; Drug Delivery Systems; Inhibitory Concentration 50; Iridium Radioisotopes | 2012 |
Immunohistochemical localization and quantitative expression of somatostatin receptors in normal human spleen and thymus: Implications for the in vivo visualization during somatostatin receptor scintigraphy.
Topics: Adolescent; Adult; Child; Female; Humans; Immunoenzyme Techniques; Male; Middle Aged; Pancreatic Neo | 2012 |
Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours.
Topics: Adult; Aged; Cost-Benefit Analysis; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; M | 2012 |
Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT in Germany: two sides of two different coins.
Topics: Female; Humans; Male; Multimodal Imaging; Neuroendocrine Tumors; Octreotide; Organometallic Compound | 2012 |
Intraoperative gamma probe detection of insulinoma in an elderly patient with pancreatic cystic lesions.
Topics: Aged; Aged, 80 and over; Female; Humans; Indium Radioisotopes; Insulinoma; Intraoperative Period; Oc | 2002 |
Peptide receptor radionuclide therapy in vitro using [111In-DTPA0]octreotide.
Topics: Animals; Apoptosis; Dose-Response Relationship, Radiation; Electrons; Indium Radioisotopes; Octreoti | 2003 |
Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.
Topics: Animals; Drug Evaluation, Preclinical; Drug Stability; Heterocyclic Compounds, 1-Ring; Indium Radioi | 2003 |
Subcellular localization of radiolabeled somatostatin analogues: implications for targeted radiotherapy of cancer.
Topics: Animals; Cell Line, Tumor; Cell Nucleus; Copper Radioisotopes; Octreotide; Organometallic Compounds; | 2003 |
GOT1 xenografted to nude mice: a unique model for in vivo studies on SSTR-mediated radiation therapy of carcinoid tumors.
Topics: Animals; Carcinoid Tumor; Disease Models, Animal; Indium Radioisotopes; Mice; Mice, Nude; Neoplasm T | 2004 |
111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.
Topics: Animals; Biomarkers, Tumor; Body Weight; Cell Line, Tumor; Dose-Response Relationship, Radiation; Ma | 2005 |
In vivo and in vitro inhibition of pancreatic cancer growth by targeted alpha therapy using 213Bi-CHX.A"-C595.
Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Bismuth; Cell Line, Tumor; Humans; Isothiocyana | 2005 |
Intraoperative gamma probe detection of lymph node recurrence of insulinoma.
Topics: Aged; Female; Humans; Insulinoma; Intraoperative Care; Lymph Node Excision; Lymphatic Metastasis; Oc | 2005 |
Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
Topics: Animals; Male; Metabolic Clearance Rate; Octreotide; Organ Specificity; Organometallic Compounds; Or | 2005 |
Treatment of advanced endocrine gastroenteropancreatic tumours using radiolabelled somatostatin analogues.
Topics: Antineoplastic Agents, Hormonal; Endocrine Gland Neoplasms; Gastrointestinal Neoplasms; Humans; Octr | 2005 |
False-positive In-111 DTPA octreotide scintigraphy resulting from lung abscess in a patient with metastatic neuroendocrine pancreatic neoplasm.
Topics: Diagnosis, Differential; False Positive Reactions; Humans; Liver Neoplasms; Lung Abscess; Lung Neopl | 2006 |
A comparison of biodistribution between 111In-DTPA octreotide and 111In-DOTATOC in rats bearing pancreatic tumors.
Topics: Animals; Indium Radioisotopes; Male; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Pentet | 2006 |
Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumors.
Topics: Animals; Biomarkers, Tumor; Drug Delivery Systems; Drug Design; Female; Isotope Labeling; Metabolic | 2006 |
In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Female; Ferritins; Heterocyclic Compounds, 1-Ring | 2007 |
[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma.
Topics: Animals; Cell Proliferation; Female; Glucagon-Like Peptide-1 Receptor; Indium Radioisotopes; Insulin | 2007 |
The use of iron and gadolinium chelates as NMR contrast agents: animal and human studies.
Topics: Abdominal Neoplasms; Animals; Brain Neoplasms; Colonic Neoplasms; Contrast Media; Edetic Acid; Ferri | 1984 |
Evaluation in vitro and in rats of 161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy.
Topics: Animals; Brain; Kidney; Liver; Male; Octreotide; Pancreatic Neoplasms; Pentetic Acid; Radioisotopes; | 1995 |
Somatostatin receptor scintigraphy in carcinoids, gastrinomas and Cushing's syndrome.
Topics: Carcinoid Tumor; Cushing Syndrome; Gastrinoma; Gastrointestinal Neoplasms; Humans; Indium Radioisoto | 1994 |
[Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
Topics: Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoid Tumor; Carcinoma, Medullary; False Posi | 1995 |
[Static and dynamic MR tomography of the pancreas: contrast media kinetics of the normal pancreatic parenchyma in pancreatic carcinoma and chronic pancreatitis].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Chronic Disease; Contrast Media; Diagnosis, Differential; F | 1995 |
Indium-111 activity concentration in tissue samples after intravenous injection of indium-111-DTPA-D-Phe-1-octreotide.
Topics: Abdominal Neoplasms; Adult; Aged; Carcinoid Tumor; Chronic Disease; Female; Humans; Indium Radioisot | 1995 |
[Somatostatin receptor scintigraphy in preoperative diagnosis of the site of endocrine gastrointestinal tumors].
Topics: Biomarkers, Tumor; Carcinoid Tumor; Gastrinoma; Gastrointestinal Neoplasms; Humans; Indium Radioisot | 1994 |
Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison.
Topics: Bone Neoplasms; Duodenal Neoplasms; Female; Humans; Indium Radioisotopes; Liver Neoplasms; Male; Med | 1994 |
A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide.
Topics: Animals; Indium Radioisotopes; Male; Octreotide; Pancreatic Neoplasms; Pentetic Acid; Radionuclide I | 1994 |
Small pancreatic adenocarcinomas: efficacy of MR imaging with fat suppression and gadolinium enhancement.
Topics: Adenocarcinoma; Aged; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic R | 1994 |
Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. A case history.
Topics: Female; Follow-Up Studies; Glucagonoma; Humans; Indium Radioisotopes; Liver Neoplasms; Middle Aged; | 1994 |
Localization of gastroenteropancreatic neuroendocrine tumors with 111indium-pentetreotide scintigraphy.
Topics: Diagnostic Imaging; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Image Enhancement; Indium | 1994 |
Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.
Topics: Carcinoid Tumor; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Neuroendocrine Tumors; Oc | 1994 |
[Fat-suppressed MR imaging sequences in the diagnosis of liver and pancreatic neoplasms at 1.5 tesla].
Topics: Adipose Tissue; Adult; Artifacts; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver | 1994 |
Gallbladder visualization with In-111 labeled octreotide.
Topics: False Negative Reactions; False Positive Reactions; Fasting; Female; Gallbladder; Humans; Indium Rad | 1994 |
Biodistribution of 111In-pentetreotide and dosimetric considerations with respect to somatostatin receptor expressing tumor burden.
Topics: Biomarkers, Tumor; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Octreotide; Pancreatic | 1993 |
Receptor scintigraphy with 111In-pentetreotide for endocrine gastroenteropancreatic tumors.
Topics: Aged; Carcinoid Tumor; Gastrinoma; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Insulin | 1993 |
Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression.
Topics: Adenoma, Islet Cell; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; | 1993 |
Distribution and elimination of the somatostatin analogue (111In-DTPA-D-Phe1)-Octreotide (OctreoScan111).
Topics: Adenoma, Islet Cell; Adult; Aged; Carcinoid Tumor; Chromatography, Gel; Endocrine Gland Neoplasms; F | 1993 |
OctreoScan 111 for imaging of a somatostatin receptor-positive islet cell tumor in rat.
Topics: Adenoma, Islet Cell; Animals; Indium Radioisotopes; Iodine Radioisotopes; Octreotide; Pancreatic Neo | 1993 |
Rapid dynamic contrast-enhanced magnetic resonance imaging of the liver and portal vein.
Topics: Gadolinium DTPA; Hepatic Artery; Hepatic Veins; Humans; Liver; Liver Diseases; Liver Neoplasms; Magn | 1993 |
In vitro and in vivo evaluation of copper-64-octreotide conjugates.
Topics: Adrenal Glands; Animals; Copper Radioisotopes; Female; Indium Radioisotopes; Male; Mice; Octreotide; | 1995 |
In vitro and in vivo studies of substance P receptor expression in rats with the new analog [indium-111-DTPA-Arg1]substance P.
Topics: Animals; Arthritis, Experimental; Biphenyl Compounds; Female; Indium Radioisotopes; Male; Neurokinin | 1996 |
3DFT-flash MR imaging of pancreatic cancer with gadopentetate dimeglumine.
Topics: Adult; Aged; Contrast Media; Drug Combinations; Female; Fourier Analysis; Gadolinium DTPA; Humans; M | 1996 |
Cost-effectiveness analysis of somatostatin receptor scintigraphy.
Topics: Carcinoid Tumor; Carcinoma, Medullary; Carcinoma, Small Cell; Cost-Benefit Analysis; Costs and Cost | 1996 |
[Carcinoma of the pancreas. Typical and atypical aspects using midfield-strength magnetic resonance].
Topics: Aged; Artifacts; Carcinoma; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Liver Neopl | 1995 |
Somatostatin receptor-binding peptides labeled with technetium-99m: chemistry and initial biological studies.
Topics: Amino Acid Sequence; Animals; Chelating Agents; Humans; Mass Spectrometry; Molecular Sequence Data; | 1996 |
[A case of metastatic gastrinomas in the liver visualized by 111In-DTPA-D-Phe-octreotide (111In-pentetreotide)].
Topics: Female; Gastrinoma; Humans; Indium Radioisotopes; Liver Neoplasms; Middle Aged; Octreotide; Pancreat | 1996 |
Intense uptake of In-111 satumomab pendetide in an inflammatory mass.
Topics: Antibodies, Monoclonal; Humans; Indium Radioisotopes; Inflammation; Oligopeptides; Pancreatic Neopla | 1996 |
[The value of 3-phase spiral CT and magnetic resonance tomography in preoperative diagnosis of pancreatic carcinoma].
Topics: Adult; Aged; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance | 1996 |
Radioisotope-guided surgery in patients with neuroendocrine tumours.
Topics: Carcinoid Tumor; Carcinoma, Medullary; Humans; Indium Radioisotopes; Neuroendocrine Tumors; Octreoti | 1996 |
Pancreatic adenocarcinoma: assessment of vascular invasion with high-field MR imaging and a phased-array coil.
Topics: Abdomen; Adenocarcinoma; Blood Vessels; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Re | 1996 |
Distinguishing small hepatic hemangiomas from vascular liver metastases in gastrinoma: use of a somatostatin-receptor scintigraphic agent.
Topics: Adult; Aged; Diagnosis, Differential; Female; Gastrinoma; Hemangioma; Humans; Indium Radioisotopes; | 1997 |
Indium-111-diethylenetriaminepentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor cell, renal, and hepatocyte lysosomes.
Topics: Adenocarcinoma; Animals; Female; Indium Radioisotopes; Kidney Neoplasms; Liver; Lysosomes; Octreotid | 1997 |
High-resolution MRI of pancreatic masses with a new circularly polarized body phased-array coil.
Topics: Aged; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; | 1997 |
Somatostatin receptor scintigraphy of malignant somatostatinoma with indium-111-pentetreotide.
Topics: Female; Humans; Indium Radioisotopes; Liver Neoplasms; Middle Aged; Octreotide; Pancreatic Neoplasms | 1997 |
In vitro and in vivo detection of functional somatostatin receptors in canine insulinomas.
Topics: Animals; Autoradiography; Blood Glucose; Dogs; Female; Indium Radioisotopes; Insulin; Insulinoma; Io | 1997 |
Somatostatin receptor scintigraphy using [111In-DTPA0]RC-160 in humans: a comparison with [111In-DTPA0]octreotide.
Topics: Adenocarcinoma, Follicular; Adult; Carcinoma, Medullary; Female; Humans; Indium Radioisotopes; Insul | 1998 |
Synthesis and characterisation of [90Y]-Bz-DTPA-oct: a yttrium-90-labelled octreotide analogue for radiotherapy of somatostatin receptor-positive tumours.
Topics: Animals; Drug Stability; Half-Life; Humans; Indicators and Reagents; Male; Octreotide; Pancreatic Ne | 1998 |
Internalization of radiolabelled [DTPA0]octreotide and [DOTA0,Tyr3]octreotide: peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy.
Topics: Animals; Binding, Competitive; Biological Transport; Carcinoma; Cell Line; Humans; Indium Radioisoto | 1998 |
Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging.
Topics: Adolescent; Adult; Aged; Carcinoid Tumor; Carcinoma, Medullary; Child; Female; Humans; Indium Radioi | 1998 |
Use of the somatostatin analogue octreotide to localise and manage somatostatin-producing tumours.
Topics: Aged; Antineoplastic Agents, Hormonal; Female; Humans; Liver Neoplasms; Male; Middle Aged; Octreotid | 1998 |
Evaluation of pylorus-preserving pancreatoduodenectomy with the Imanaga reconstruction by hepatobiliary and gastrointestinal dual scintigraphy.
Topics: Adult; Aged; Aged, 80 and over; Ampulla of Vater; Arteriovenous Malformations; Bile; Female; Humans; | 1999 |
Current imaging and possible therapeutic management of glucagonoma tumors: a case report.
Topics: Female; Glucagonoma; Humans; Indium Radioisotopes; Middle Aged; Octreotide; Pancreatic Neoplasms; Pe | 2000 |
Use of the rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted scintigraphy and radionuclide therapy.
Topics: Animals; Cell Line; Indium Radioisotopes; Neoplasm Transplantation; Pancreas; Pancreatic Neoplasms; | 2000 |
64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.
Topics: Adenoma, Islet Cell; Aged; Animals; Carcinoid Tumor; Female; Gastrointestinal Neoplasms; Humans; Ind | 2001 |
Role of (111)In-DTPA-pentetreotide scintigraphy in accurate diagnosis of neuroendocrine gastroenteropancreatic tumors.
Topics: Adult; Aged; Diagnosis, Differential; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Male | 2001 |
[Studies on magnetic resonance imaging of pancreatic cancer].
Topics: Contrast Media; Diagnosis, Differential; Female; Gadolinium DTPA; Humans; Lymphatic Metastasis; Magn | 1991 |
[Gadolinium-DTPA as an oral contrast medium for magnetic resonance tomography of the pancreas].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Gadolinium | 1991 |
Pancreatic disease: prospective comparison of CT, ERCP, and 1.5-T MR imaging with dynamic gadolinium enhancement and fat suppression.
Topics: Adult; Aged; Cholangiopancreatography, Endoscopic Retrograde; Contrast Media; Drug Combinations; Fem | 1991 |
Magnetic resonance imaging of the pancreas with gadolinium-DTPA.
Topics: Adenocarcinoma; Adult; Aged; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic R | 1991 |
Generation of bispecific monoclonal antibodies for two phase radioimmunotherapy.
Topics: Animals; Antibodies, Monoclonal; Colonic Neoplasms; Humans; Injections, Intravenous; Mice; Mice, Nud | 1991 |
90Y.B72.3 against pancreatic cancer: dosimetric and biological analysis.
Topics: Animals; Antibodies, Monoclonal; Carcinoma; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantati | 1990 |
[Diagnostic strategy in liver and pancreatic tumors: imaging diagnosis using MRT].
Topics: Carcinoma, Hepatocellular; Contrast Media; Gadolinium DTPA; Hemangioma; Humans; Liver Neoplasms; Mag | 1989 |
[Immunoscintigraphy of colorectal cancers and specific immunotherapy of pancreatic cancers using monoclonal antibodies].
Topics: Antibodies, Monoclonal; Antibody Specificity; Carcinoembryonic Antigen; Colorectal Neoplasms; Granul | 1988 |
Upper gastrointestinal bleeding from the biliary tract (hematobilia). Detection by technetium-99m DTPA.
Topics: Adenocarcinoma; Adult; Choledochostomy; Gastrointestinal Hemorrhage; Hemobilia; Humans; Male; Organo | 1987 |